The trial of AstraZeneca’s coronavirus vaccine is set to resume, according to a report on CNN Philippines. The trials were halted last week after one of the volunteers displayed an unexplained illness. The University of Oxford, which is developing the vaccine, announced that the trial will resume in United Kingdom for now. The vaccine was being tested in the United States, Latin America, Asia, Europe, and Africa before the trials were paused.
According to a statement issued by the university, 18,000 individuals worldwide are participating in the trial and have received study vaccines. The AstraZeneca vaccine is one of the three coronavirus vaccines currently in its late stages with Phase 3 trials in the United States. It is also backed by the US federal government. The University of Oxford however did not disclose the exact date when the trial will resume.
AstraZeneca, along with other eight companies, signed a pledge that they will wait until they had adequate data showing that the vaccine will work safely and not push for premature government approval for the vaccine.
